A Roller Coaster from Methamphetamine to Ketamine

從安非他命濫用到愷他命濫用

黃名琪(Ming-Chyi Huang)；林式穀(Shih-Ku Lin)；陳志根(Chih-Ken Chen)

甲基安非他命 ； 安非他命精神病 ； 愷他命精神病 ； 精神分裂症glutamatergic假說 ； 臺灣 ； methamphetamine ； amphetamine psychosis ； ketamine psychosis ； glutamatergic hypothesis of schizophrenia ； Taiwan

台灣精神醫學

28卷4期（2014 / 12 / 01）

217 - 231+i

英文

臺灣過去十多年來在藥物濫用盛行率方面，似有由甲基安非他命(methamphetamine)轉為愷也命(ketamine)的趨勢。臺灣的學者們有關於甲基安非他命依賴及其引發精神病之研究成果，不論是臨床特徵方面或是誘發基因之相關性調查，在相關研究領域中皆有重要的貢獻與影響。安非他命多巴胺系統的作用以及愷他命對glutamate系統的作用，在過去人體與動物研究中分別模擬了精神分裂症（思覺失調症）在正性與負性症狀的不同面向，讓學者們對精神疾病機轉上有深一的了解，從而也影響了治療。本篇文章的第一部分，我們將針對甲基安非他命濫用與甲基安非他命精神病的進行文獻探討，特別是著重在臺灣進的研究。而在第二部分，我們討論愷他命的生理機多及對人體之作用，特別是長期濫用後之各類副作用，比如膀胱問題、腹部疼痛、神經認知損傷、憂鬱症、精神病、以及成癮問題。由於有關愷他命的神經適應作用以及迴饋機制仍尚未清楚，未來仍需要更多的研究，以精進我們在其臨床使用的益處以及濫用危害的了解。

A trend of drug abuse shifting from methamphetamine (METH) to ketamine in Taiwan has been witnessed in Taiwan in the past decade. The research in examining the clinical characteristics and genetic predispositions of METH dependence and psychosis in Taiwan has had a great impact in the pertinent fields. The effects of amphetamine and ketamine have provoked interest in studying the rôle of dopamine theory and glutamatergic hypothesis in schizophrenia, both of which mimic different aspects of the illness. In the first part of this overview paper we review the studies on METH abuse and METH psychosis, particularly those conducted in Taiwan. And in the second part, we address the complex mechanisms of ketamine action and the adverse outcomes associated with chronic ketamine abuse such as cystitis, abdominal pain, neurocognitive impairment, depression, and psychosis. Because the neuroadaptation and reward related to ketamine are not entirely clear, future studies are needed to advance our understanding both its clinical uses and abuse.

1. Chiang, HY,Ku, YC,Chen, CK(2013).Dental manifestations leading to diagnosis of methamphetamine-induced psychotic disorder.Taiwanese Journal of Psychiatry,27,161-4.
   連結：
2. aan het Rot, M,Collins, KA,Murrough, JW(2010).Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.Biol Psychiatry,67,139-45.
3. Anand, A,Charney, DS,Oren, DA(2000).Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.Arch Gen Psychiatry,57,270-6.
4. Berman, S,O'Neill, J,Fears, S(2008).Abuse of amphetamines and structural abnormalities in the brain.Ann N Y Acad Sci,1141,195-220.
5. Brensilver, M,Heinzerling, KG,Swanson, AN(2012).A retrospective analysis of two randomized trials of bupropion for methamphetamine dependence: suggested guidelines for treatment discontinuation/augmentation.Drug Alcohol Depend,125,169-72.
6. Chen, CH,Lee, MH,Chen, YC(2011).Ketaminesnorting associated cystitis.J Formos Med Assoc,110,787-91.
7. Chen, CK,Chen, SL,Mill, J(2003).The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample.Mol Psychiatry,8,393-6.
8. Chen, CK,Hu, X,Lin, SK(2004).Association analysis of dopamine D2-like receptor genes and methamphetamine abuse.Psychiatr Genet,14,223-6.
9. Chen, CK,Lin, SK(2006).Reversal of antipsychotic-induced hyperprolactinemia, weight gain and dyslipidemia by aripiprazole: a case report.J Clin Psychiatry,67,1307.
10. Chen, JT,Chen, RM(2010).Mechanisms of ketamine-involved regulation of cytochrome P450 gene expression.Expert Opin Drug Metab Toxicol,6,273-81.
11. Chen, PH,Huang, MC,Lai, YC(2014).Serum brainderived neurotrophic factor levels were reduced during methamphetamine early withdrawal.Addict Biol,19,482-5.
12. Chen, WJ,Fu, TC,Ting, TT(2009).Use of ecstasy and other psychoactive substances among school-attending adolescents in Taiwan: national surveys 2004-2006.BMC Public Health,9,27.
13. Chen, WY,Huang, MC,Lin, SK(2014).Gender differences in subjective discontinuation symptoms associated with ketamine use.Subst Abuse Treat Prev Policy,9,39.
14. Chiang, SC,Chan, HY,Chen, CH(2006).Recidivism among male subjects incarcerated for illicit drug use in Taiwan..Psychiatry Clin Neurosci,60,444-51.
15. Chiang, SC,Chen, CY,Chang, YY(2007).Prevalence of heroin and methamphetamine male users in the northern Taiwan, 1999-2002: capture-recapture estimates.BMC Public Health,7,292.
16. Chou, P,Liou, MY,Lai, MY(1999).Time trend of substance use among adolescent students in Taiwan, 1991-1996.J Formos Med Assoc,98,827-31.
17. Chou, YH,Huang, WS,Su, TP(2007).Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence: A SPECT study.Eur Neuropsychopharmacol,17,46-52.
18. Chu, PS,Ma, WK,Wong, SC(2008).The destruction of the lower urinary tract by ketamine abuse: a new syndrome?.BJU Int,102,1616-22.
19. Cottrell, AM,Gillatt, D(2008).Consider ketamine misuse in patients with urinary symptoms.Practitioner,252,5.
20. Crime UNOoDa(2014).World Drug Report 2014.Crime UNOoDa. World Drug Report 2014: United Nations publication; 2014.:United Nations publication.
21. Critchlow, DG(2006).A case of ketamine dependence with discontinuation symptoms.Addiction,101,1212-3.
22. Curran, HV,Morgan, C(2000).Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later.Addiction,95,575-90.
23. Duncan, GE,Leipzig, JN,Mailman, RB(1998).Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.Brain Res,812,65-75.
24. Farnia, V,Shakeri, J,Tatari, F(2014).Randomized controlled trial of aripiprazole versus risperidone for the treatment of amphetamine-induced psychosis.Am J Drug Alcohol Abuse,40,10-5.
25. Fine, J,Finestone, SC(1973).Sensory disturbances following ketamine anesthesia: recurrent hallucinations.Anesth Analg,52,428-30.
26. Gable, RS(2004).Acute toxic effects of club drugs.J Psychoact Drugs,36,303-13.
27. Green, SM,Clark, R,Hostetler, MA(1999).Inadvertent ketamine overdose in children: clinical manifestations and outcome.Ann Emerg Med,34,492-7.
28. Hsiao, CC,Lin, SK,Liu, SC(2003).Clinical comparisons between male amphetamine abusers in a psychiatric hospital and a detention center.Taiwanese Journal of Psychiatry,17,180-8.
29. Huang, MC,Lin, SK,Chen, CH(2013).Oxidative stress status in recently abstinent methamphetamine abusers.Psychiatry Clin Neurosci,67,92-100.
30. Huang, YS,Tang, TC,Lin, CH(2011).Effects of motivational enhancement therapy on readiness to change MDMA and methamphetamine use behaviors in Taiwanese adolescents.Subst Use Misuse,46,411-6.
31. Hustveit, O,Maurset, A,Oye, I(1995).Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors.Pharmacol Toxicol,77,355-9.
32. Iyo, M,Sekine, Y,Mori, N(2004).Neuromechanism of developing methamphetamine psychosis: a neuroimaging study.Ann N Y Acad Sci,1025,288-95.
33. Jansen, KL(2000).A review of the nonmedical use of ketamine: use, users and consequences.J Psychoact Drugs,32,419-33.
34. Jansen, KL,Darracot-Cankovic, R(2001).The nonmedical use of ketamine, part two: A review of problem use and dependence.J Psychoactive Drugs,33,151-8.
35. Klein, M,Calderon, S,Hayes, B(1999).Abuse liability assessment of neuroprotectants.Ann N Y Acad Sci,890,515-25.
36. Kohrs, R,Durieux, ME(1998).Ketamine: teaching an old drug new tricks.Anesth Analg,87,1186-93.
37. Krystal, JH,Karper, LP,Seibyl, JP(1994).Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.Arch Gen Psychiatry,51,199-214.
38. Kuo, CJ,Liao, YT,Chen, WJ(2011).Causes of death of patients with methamphetamine dependence: a record-linkage study.Drug Alcohol Rev,30,621-8.
39. Kuo, CJ,Tsai, SY,Liao, YT(2012).Elevated aspartate and alanine aminotransferase levels and natural death among patients with methamphetamine dependence.PLoS One,7,e29325.
40. Kuo, CJ,Tsai, SY,Liao, YT(2011).Risk and protective factors for suicide among patients with methamphetamine dependence: a nested case-control study.J Clin Psychiatry,72,487-93.
41. Langston, WT,Wathen, JE,Roback, MG(2008).Effect of ondansetron on the incidence of vomiting associated with ketamine sedation in children: a doubleblind, randomized, placebo-controlled trial.Ann Emerg Med,52,30-4.
42. Leelahanaj, T,Kongsakon, R,Netrakom, P(2005).A 4-week, double-blind comparison of olanzapine with haloperidol in the treatment of amphetamine psychosis.J Med Assoc Thai,88(Suppl 3),S43-52.
43. Levanen, J,Makela, ML,Scheinin, H(1995).Dexmedetomidine premedication attenuates ketamine-induced cardiostimulatory effects and postanesthetic delirium.Anesthesiology,82,1117-25.
44. Li, JH,Vicknasingam, B,Cheung, YW(2011).To use or not to use: an update on licit and illicit ketamine use.Subst Abuse Rehabil,2,11-20.
45. Li, T,Chen, CK,Hu, X(2004).Association analysis of the DRD4 and COMT genes in methamphetamine abuse.AmJ Med Genet B Neuropsychiatr Genet,129B,120-4.
46. Liao, Y,Tang, J,Corlett, PR(2011).Reduced dorsal prefrontal gray matter after chronic ketamine use.Biol Psychiatry,69,42-8.
47. Liao, Y,Tang, J,Ma, M(2010).Frontal white matter abnormalities following chronic ketamine use: a diffusion tensor imaging study.Brain,133,2115-22.
48. Lim, DK(2003).Ketamine associated psychedelic effects and dependence.Singapore Med J,44,31-4.
49. Lin, SK,Ball, D,Hsiao, CC(2004).Psychiatric comorbidity and gender differences of persons incarcerated for methamphetamine abuse in Taiwan.Psychiatry Clin Neurosci,58,206-12.
50. Lin, SK,Huang, MC,Lin, HC(2010).Deterioration of intelligence in methamphetamine-induced psychosis: comparison with alcohol dependence on WAIS-III.Psychiatry Clin Neurosci,64,4-9.
51. Lu, Y,France, CP,Woods, JH(1992).Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists.J Pharmacol Exp Ther,263,499-504.
52. Malhotra, AK,Pinals, DA,Adler, CM(1997).Ketamineinduced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.Neuropsychopharmacology,17,141-50.
53. Mathias, S,Lubman, DI,Hides, L(2008).Substance-induced psychosis: a diagnostic conundrum.J Clin Psychiatry,69,358-67.
54. McKetin, R,McLaren, J,Lubman, DI(2006).The prevalence of psychotic symptoms among methamphetamine users.Addiction,101,1473-8.
55. Miller, KW(2002).The nature of sites of general anaesthetic action.Br J Anaesth,89,17-31.
56. Mion, G,Villevieille, T(2013).Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent fi ndings).CNS Neurosci Ther,19,370-80.
57. Morgan, CJ,Curran, HV(2006).Acute and chronic effects of ketamine upon human memory: a review.Psychopharmacology,188,408-24.
58. Morgan, CJ,Curran, HV,Independent Scientific Committee onD(2012).Ketamine use: a review.Addiction,107,27-38.
59. Morgan, CJ,Muetzelfeldt, L,Curran, HV(2010).Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study.Addiction,105,121-33.
60. Morgan, CJ,Rees, H,Curran, HV(2008).Attentional bias to incentive stimuli in frequent ketamine users.Psychol Med,38,1331-40.
61. Muetzelfeldt, L,Kamboj, SK,Rees, H(2008).Journey through the K-hole: phenomenological aspects of ketamine use.Drug Alcohol Depend,95,219-29.
62. Murray, RM,Paparelli, A,Morrison, PD(2013).What can we learn about schizophrenia from studying the human model, drug-induced psychosis?.Am J Med Genet B Neuropsychiatr Genet,162B,661-70.
63. Nakamura, K,Chen, CK,Sekine, Y(2006).Association analysis of SOD2 variants with methamphetamine psychosis in Japanese and Taiwanese populations.Hum Genet,120,243-52.
64. Naughton, M,Clarke, G,O'Leary, OF(2014).A review of ketamine in affective disorders: current evidence of clinical effi cacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.J Affect Disord,156,24-35.
65. Olney, JW,Wozniak, DF,Jevtovic-Todorovic, V(2002).Drug-induced apoptotic neurodegeneration in the developing brain.Brain Pathol,12,488-98.
66. Poon, TL,Wong, KF,Chan, MY(2010).Upper gastrointestinal problems in inhalational ketamine abusers.J Dig Dis,11,106-10.
67. Raeder, JC,Stenseth, LB(2000).Ketamine: a new look at an old drug.Curr Opin Anaesthesiol,13,463-8.
68. Razoux, F,Garcia, R,Lena, I(2007).Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens.Neuropsychopharmacology,32,719-27.
69. Salo, R,Ravizza, S,Fassbender, C(2011).Overlapping cognitive patterns in schizophrenia and methamphetamine dependence.Cogn Behav Neurol,24,187-93.
70. Schifano, F,Corkery, J,Oyefeso, A(2008).Trapped in the "K-hole": overview of deaths associated with ketamine misuse in the UK (1993-2006).J Clin Psychopharmacol,28,114-6.
71. Schuckit, MA(2006).Comorbidity between substance use disorders and psychiatric conditions.Addiction,101(Suppl 1),76-88.
72. Shahani, R,Streutker, C,Dickson, B(2007).Ketamineassociated ulcerative cystitis: a new clinical entity.Urology,69,810-2.
73. Tan, S,Lam, WP,Wai, MS(2012).Chronic ketamine administration modulates midbrain dopamine system in mice.PLoS One,7,e43947.
74. Uhl, GR,Drgon, T,Liu, QR(2008).Genome-wide association for methamphetamine dependence: convergent results from 2 samples.Arch Gen Psychiatry,65,345-55.
75. Verachai, V,Rukngan, W,Chawanakrasaesin, K(2014).Treatment of methamphetamine-induced psychosis: a double-blind randomized controlled trial comparing haloperidol and quetiapine.Psychopharmacology,231,3099-108.
76. Wang, GJ,Smith, L,Volkow, ND(2012).Decreased dopamine activity predicts relapse in methamphetamine abusers.Mol Psychiatry,17,918-25.
77. Wang, LJ,Chiang, SC,Su, LW(2012).Factors associated with drug-related psychiatric disorders and suicide attempts among illicit drug users in Taiwan.Subst Use Misuse,47,1185-8.
78. Weber, E,Blackstone, K,Iudicello, JE(2012).Neurocognitive defi cits are associated with unemployment in chronic methamphetamine users.Drug Alcohol Depend,125,146-53.
79. Wong, SW,Lee, KF,Wong, J(2009).Dilated common bile ducts mimicking choledochal cysts in ketamine abusers.Hong Kong Med J,15,53-6.
80. Yan, J,Jiang, H(2014).Dual effects of ketamine: neurotoxicity versus neuroprotection in anesthesia for the developing brain.J Neurosurg Anesthesiol,26,155-60.
81. Yen, CF,Chong, MY(2006).Comorbid psychiatric disorders, sex, and methamphetamine use in adolescents: a case-control study.Compr Psychiatry,47,215-20.
82. Yu, WL,Cho, CC,Lung, PF(2014).Ketamine-related cholangiopathy: a retrospective study on clinical and imaging findings.Abdom Imaging,39,1241-6.

1. 鄭映芝,黃名琪,陳枻志,陳志根,林式穀,王亮人(2016)。Substance Use Patterns and Cognitive Function in Patients with Methamphetamine Use: A Study of 131 Cases。臺灣精神醫學，30(2)，128-136+iv。